col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


5 Results       Page 1

 [1] 
American Chemical Society: Organic Letters
  original article Date Title Authors   All Authors
1 [GO] 2025―Oct―30 Asymmetric Synthesis of MK-7845, an Investigational Treatment for COVID-19 Reed T. Larson, Ben W. H. Turnbull, Patrick J. Moon, Dan Lehnherr, Jonathan M. E. Hughes, Stasik Popov, et al. (+35)
2 [GO] 2024―Jun―27 Synthesis of Structural ADP-Ribose Analogues as Inhibitors for SARS-CoV-2 Macrodomain 1 Koen J. Rijpkema, Marion Schuller, Miriam S. van der Veer, Sjoerd Rieken, Diego L. R. Chang, Pascal Balić, et al. (+8)
3 [GO] 2023―Jul―31 Deuteration for Metabolic Stabilization of SARS-CoV-2 Inhibitors GC373 and Nirmatrelvir Tayla J. Van Oers, Alexia Piercey, Alexandr Belovodskiy, Béla Reiz, Bethan L. Donnelly, Wayne Vuong, et al. (+4)
4 [GO] 2023―Jun―26 Synthetic Analogs of the Sponge Sesterterpenoid Alotaketal C are Potent Inhibitors of SARS-CoV-2 Omicron BA.1 and BA.5 Infections of Human Lung Cells Polina Blagojevic, Jimena Perez-Vargas, Kunzhong Jian, David E. Williams, Ivan Villanueva, Connor A. H. Thompson, et al. (+5)
5 [GO] 2022―Dec―07 A 1-Pot Synthesis of the SARS-CoV-2 Mpro Inhibitor Nirmatrelvir, the Key Ingredient in Paxlovid Juan C. Caravez, Karthik S. Iyer, Rahul D. Kavthe, Joseph R. A. Kincaid, Bruce H. Lipshutz
 [1] 

5 Results       Page 1



[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.004 sec